Want to see HK:9989 full AI Analyst Report?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Earnings Dates, Call Summary & Reports
Earnings Data
- Estimated Report Date
- Apr 01, 2027
- Period Ending
- 2026 (Q4)
- Consensus EPS Forecast
- 0.12
- Last Year’s EPS
- 0.15
TBA (Not Confirmed)
Same Quarter Last Year
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
HK:9989 Q3 2026 Earnings Report
HK:9989 Upcoming Earnings
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's next earnings date is estimated for April 1, 2027, based on past reporting schedules.
HK:9989 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | 0.12- | 0.15 | ― | ― | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.220.10 | 0.1 | -3.06% (-0.00) | ― | ― | |
| Aug 28, 2026 | 2026 (Q2) | 0.090.07 | 0.2 | -64.47% (-0.13) | ― | ― | |
| Apr 29, 2026 | 2026 (Q1) | 0.130.15 | 0.11 | 28.95% (+0.03) | ― | ― | |
| Mar 30, 2026 | 2025 (Q4) | -0.17-0.16 | -0.1 | -67.71% (-0.07) | ― | ― | |
| Oct 30, 2025 | 2025 (Q3) | 0.100.10 | 0.09 | 12.64% (+0.01) | ― | ― | |
| Aug 29, 2025 | 2025 (Q2) | 0.020.20 | 0.38 | -48.70% (-0.19) | ― | ― | |
| Apr 24, 2025 | 2025 (Q1) | 0.100.11 | 0.11 | 0.00% (+0.00) | ― | ― | |
| Mar 28, 2025 | 2024 (Q4) | -0.12-0.10 | -0.68 | 85.92% (+0.59) | ― | ― | |
| Oct 30, 2024 | 2024 (Q3) | 0.080.09 | 0.01 | 521.43% (+0.07) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
HK:9989 Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 29, 2026 | HK$3.88 | HK$3.94 | +1.42% |
| Aug 28, 2026 | HK$4.39 | HK$4.32 | -1.59% |
| Apr 29, 2026 | HK$4.63 | HK$4.66 | +0.63% |
| Mar 30, 2026 | HK$4.77 | HK$4.68 | -2.03% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) report earnings?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) is estimated to report earnings on Apr 01, 2027, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is HK:9989 EPS forecast?
HK:9989 EPS forecast for the fiscal quarter 2026 (Q4) is 0.12.